www.fdanews.com/articles/82559-reliant-pharmaceuticals-pulls-ipo-due-to-conditions
RELIANT PHARMACEUTICALS PULLS IPO DUE TO CONDITIONS
November 18, 2005
Reliant Pharmaceuticals Inc., which markets branded cardiovascular pharmaceutical products, on Thursday withdrew its planned $300 million initial public offering due to unfavorable market conditions. Since filing a preliminary offering document with the U.S. Securities and Exchange Commission in May, the company had not revealed the amount of shares or the estimated price range.